New Medicines, Novel Insights: Accelerating development of cell and gene therapies

Cell and gene therapies offer extraordinary hope to patients with advanced cancers and genetic diseases but pose unprecedented challenges for sponsors. In this report, Parexel experts share insights that can bring these complex treatments to market faster and more efficiently.

Explore the report

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Article

Bringing clinical trials to patients with the decentralized model

Jan 8, 2021

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Article

Three ways to work with the FDA for better patient-focused trials

Jul 29, 2021

Article

Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct

Sep 14, 2021

Video

Part 3: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Webinar

Use of AI to develop health economic evidence for optimized patient access

Sep 6, 2023

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023